Hepatocyte growth factor controls bone marrow rejection

Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function of donor cells.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Acute graft-versus-host disease (GVHD) is a major complication of bone marrow transplantation. In June 1 Journal of Clinical Investigation, Takanori Kuroiwa and colleagues from Hyogo College of Medicine, Nishinomiya, Japan show that hepatocyte growth factor (HGF) — a potent mitogen for hepatocytes — ameliorates acute graft-versus-host disease and promotes hematopoietic function.

Kuroiwa et al used a murine model of GVHD in which they performed repeated transfection of the human HGF cDNA by liposome injection into the gluteal muscle. This treatment inhibited apoptosis of intestinal epithelial cells and donor T-cell infiltration into the liver, thereby ameliorating the enteropathy and liver injury caused by acute GVHD. In addition, the HGF gene transfer induced an increase of extramedullary hematopoiesis by donor cells in the spleen and liver (J Clin Invest, 2001, 107:1365-1373).

These results open the possibility of the use of HGF gene therapy to control acute GVHD following allogeneic bone marrow transplantation.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tudor Toma

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development